SMAD1 and diffuse large B-cell lymphoma: Consistently, in vitro studies have demonstrated that the hypermethylation of SMAD1, a key transducer of TGF-β signaling, contributes to the development of chemoresistance in DLBCL cells exposed to R-CHOP treatment [52].